The announcement was made during Cardona´s official three-day trip to Puerto Rico, the first for a Biden administration Cabinet member. It marks the first time the island has full access to those funds. Although the company will continue to pursue “higher-risk, high reward” drug candidates such as pegilodecakin, these will be a smaller part of...